No abstract available
MeSH terms
-
Fatal Outcome
-
Female
-
Fibrinolytic Agents / adverse effects*
-
Humans
-
Middle Aged
-
Myocardial Infarction / etiology*
-
Recombinant Proteins / adverse effects
-
Stroke / drug therapy*
-
Thromboembolism / etiology*
-
Tissue Plasminogen Activator / adverse effects*
-
Tissue Plasminogen Activator / genetics
Substances
-
Fibrinolytic Agents
-
Recombinant Proteins
-
Tissue Plasminogen Activator